Cigarette smoke alters non-neuronal cholinergic system components inducing MUC5AC production in the H292 cell line

European Journal of Pharmacology

Volumn 736, Issue , 2014, Pages 35-43

  Montalbano, Angela Marina ^a   Albano, Giusy Daniela ^a,b   Anzalone, Giulia ^a   Bonanno, Anna ^a   Riccobono, Loredana ^a   Di Sano, Caterina ^a   Gagliardo, Rosalia ^a   Siena, Liboria ^a   Pieper, Michael Paul ^c   Gjomarkaj, Mark ^a   Profita, Mirella ^a  

^a CNR Consiglio Nazionale delle Ricerche   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

^c BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

Anticholinergic drugs; Choline Acetyl Transferase; Cigarette smoke; Mucin production

Indexed keywords

ACETYLCHOLINE; CHOLINE ACETYLTRANSFERASE; CIGARETTE SMOKE; FLUTICASONE PROPIONATE; HEMICHOLINIUM 3; MUCIN 5AC; MUSCARINIC M3 RECEPTOR; SALMETEROL; TIOTROPIUM BROMIDE; ANDROSTANE DERIVATIVE; BRONCHODILATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; DRUG MIXTURE; FLUTICASONE; MUC5AC PROTEIN, HUMAN; NEUROTRANSMITTER UPTAKE INHIBITOR; SALBUTAMOL; SCOPOLAMINE DERIVATIVE; SMOKE;

ARTICLE; BRONCHUS MUCOSA; CANCER CELL LINE; CHOLINERGIC SYSTEM; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; HUMAN; HUMAN CELL; MOLECULAR INTERACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA INTERFERENCE; UPREGULATION; ANALOGS AND DERIVATIVES; BRONCHUS; CYTOLOGY; DRUG EFFECTS; DRUG MIXTURE; EPITHELIUM CELL; GENETICS; METABOLISM; PHARMACOLOGY; SMOKE; TOBACCO; TUMOR CELL LINE;

ACETYLCHOLINE; ALBUTEROL; ANDROSTADIENES; BRONCHI; BRONCHODILATOR AGENTS; CELL LINE, TUMOR; CHOLINE O-ACETYLTRANSFERASE; CHOLINERGIC ANTAGONISTS; COMPLEX MIXTURES; EPITHELIAL CELLS; HEMICHOLINIUM 3; HUMANS; MUCIN 5AC; NEUROTRANSMITTER UPTAKE INHIBITORS; RECEPTOR, MUSCARINIC M3; RNA INTERFERENCE; SCOPOLAMINE DERIVATIVES; SMOKE; TOBACCO;

EID: 84900362489     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2014.04.022     Document Type: Article

References (45)

1. R. Aalbers, J. Ayres, M. Decramer, P.A. Lier, P. Magyar, J. Malolepszy, R. Ruffin, and G.W. Sybrecht Formoterol in patients with chronic obstructive pulmonary disease: a randomized, controlled, 3-month trial Eur. Respir. J. 19 2002 936 943
2. S.F. Abad, J. Novalbos, S.S. Gallego, and M.A. Galvez Mugica [Regulation of bronchial tone in chronic obstructive pulmonary disease (COPD): role of muscarinic receptors] Regulacion del tono bronquial en la enfermedad pulmonar obstructiva cronica (EPOC): papel de los receptores muscarinicos An. Med. Interna 20 2003 201 205
3. R.G. Andersson, and N. Grundstrom Innervation of airway smooth muscle. Efferent mechanisms Pharmacol. Ther. 32 1987 107 130
4. N. Arai, M. Kondo, T. Izumo, J. Tamaoki, and A. Nagai Inhibition of neutrophil elastase-induced goblet cell metaplasia by tiotropium in mice Eur. Respir. J. 35 2010 1164 1171
5. N.C. Barnes, J. Evans, J.T. Zakrzewski, P.J. Piper, and J.F. Costello A critical evaluation of the clinical relevance of leukotrienes in bronchial asthma Agents Actions Suppl. 28 1989 123 133
6. E.D. Bateman, S. Rennard, P.J. Barnes, P.V. Dicpinigaitis, R. Gosens, N.J. Gross, J.A. Nadel, M. Pfeifer, K. Racke, K.F. Rabe, B.K. Rubin, T. Welte, and I. Wessler Alternative mechanisms for Tiotropium Pulm. Pharmacol. Ther. 22 6 2009 533 542
7. J. Berger, R.E. Albert, K. Sanborn, and M. Lippmann Effects of atropine and methacholine on deposition and clearance of inhaled particles in the donkey J. Toxicol. Environ. Health 4 1978 587 604
8. P.S. Burge, P.M.A. Calverley, P.W. Jones, J.A. Anderson, and T.K. Maslen Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructiv pulmonary disease: the ISOLDE trial Br. Med. J. 320 2000 1297 1303
9. P.M.A. Calverley, J.A. Anderson, B.R. Celli, G.T. Ferguson, C. Jenkins, P.W. Jones, J. Yates, and J. Vestbo Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease N. Engl. J. Med. 356 2007 775 789
10. P. Cammer, K. Strandberg, and K. Philipson Increased mucociliary transport by cholinergic stimulation Arch. Environ. Health 29 1974 220 224
11. G. Caramori, P. Casolari, C. Di Gregorio, M. Saetta, S. Baraldo, P. Boschetto, K. Ito, M.L. Fabbri, P.J. Barnes, I.M. Adcock, G. Cavallesco, K.F. Chung, and A. Papi MUC5AC expression is increased in bronchial submucosal glands of stable COPD patients Histopathology 55 2009 321 331
12. J. Cortijo, M. Mata, J.E. Milara, A. Donet, M. Gavalda, and E.J. Miralpeix Morcillo Aclidinium inhibits cholinergic and tobacco smoke-induced MUC5AC in human airways Eur. Respir. J. 37 2011 244 254
13. F.R. Coulson, and A.D. Fryer Muscarinic acetylcholine receptors and airway diseases Pharmacol. Ther. 98 2003 59 69
14. D.R. Curran, and L. Cohn Advances in mucous cell metaplasia: a plug for mucus as a therapeutic focus in chronic airway disease Am. J. Respir. Cell Mol. Biol. 42 3 2010 268 275
15. J.R. Davies, H.W. Hovenberg, C.J. Lindén, R. Howard, P.S. Richardson, J.K. Sheehan, and I. Carlstedt Mucins in airway secretions from healthy and chronic bronchitic subjects Biochem. J. 313 1996 431 439
16. D. Dusser, M.L. Bravo, and P. Iacono The effect of Tiotropium on exacerbations and airflow in patients with COPD Eur. Respir. J. 27 2006 547 555
17. L.A. Gatto Cholinergic and adrenergic stimulation of mucociliary transport in the rat trachea Respir. Physiol. 92 1993 209 217
18. R. Gosens, J. Zaagsma, M. Grootte Bromhaar, A. Nelemans, and H. Meurs Acetylcholine: a novel regulator of airway smooth muscle remodelling? Eur. J. Pharmacol. 500 1-3 2004 193 201
19. R. Gosens, J. Zaagsma, H. Meurs, and A.J. Halayko Muscarinic receptor signaling in the pathophysiology of asthma and COPD Respir. Res. 7 2006 73
20. K.H. Groenewegen, D.S. Postma, W.C. Hop, P.L.M.L Wielders, N.J.J Schlösser, and E.F.M. Wouters Increased systemic inflammation is a risk factor for COPD exacerbations Chest 133 2008 350 357
21. M. Johnson Corticosteroids: potential β2-agonist and anticholinergic interactions in chronic obstructive pulmonary disease Proc. Am. Thorac. Soc. 2 4 2005 320 325
22. P.W. Jones, and T.K. Bosh Quality of life changes in COPD patients treated with salmeterol Am. J. Respir. Crit. Care Med. 155 1997 1283 1289
23. P.W. Jones, L.R. Willits, P.S. Burge, and P.M.A. Calverley Disease severity and the effect of fluticasone propionate on chronic obstructive pulmonary diasase exacerbations Eur. Respir. J. 21 2003 68 73
24. S. Kim, A.J. Schein, and J.A. Nadel E-cadherin promotes EGFR-mediated cell differentiation and MUC-5AC mucin expression in cultured human airway epithelial cells Am. J. Physiol. - Lung Cell. Mol. Physiol. 289 2005 L1049 L1060
25. D.A. Mahler, J.F. Donohue, R.A. Barbee, M.D. Goldman, N.J. Gross, M.E. Wisniewski, S.W. Yancey, B.A. Zakes, K.A. Rickard, and W.H. Anderson Efficacy of salmeterol xinafoate in the treatment of COPD Chest 115 1999 957 965
26. N. Newland, and A. Richter Agents associated with lung inflammation induce similar responses in H292 lung epithelial cells Toxicol. in vitro 22 7 2008 1782 1788
27. D.W. Perng, C.W. Tao, K.C. Su, C.C. Tsai, L.Y. Liu, and Y.C. Lee Anti-inflammatory effects of salmeterol/fluticasone, Tiotropium/fluticasone or Tiotropium in COPD Eur. Respir. J. 38 2009 778 784
28. R.J. Phipps, I.P. Williams, P.S. Richardson, J. Pell, R.J. Pack, and N. Wright Sympathomimetic drugs stimulate the output of secretory glycoproteins from human bronchi in vitro Clin. Sci. 63 1982 23 28
29. D.J. Powrie, T.M.A. Wilkinson, G.C. Donaldson, P. Jones, K. Scrine, K. Viel, S. Kesten, and J.A. Wedzicha Effect of Tiotropium on sputum and serum inflammatory markers and exacerbations in COPD Eur. Respir. J. 30 2007 472 478
30. M. Profita, R. Di Giorgi, A. Sala, A. Bonanno, L. Riccobono, F. Mirabella, M. Gjomarkaj, G. Bonsignore, J. Bousquet, and A.M. Vignola Muscarinic receptors, leukotriene B4 production and neutrophilic inflammation in COPD patients Allergy 60 11 2005 1361 1369
31. M. Profita, A. Bonanno, L. Siena, M. Ferraro, A.M. Montalbano, F. Pompeo, L. Riccobono, M.P. Pieper, and M. Gjomarkaj Acetylcholine mediates the release of IL-8 in human bronchial epithelial cells by a NFkB/ERK-dependent mechanism Eur. J. Pharmacol. 582 1-3 2008 145 153
32. M. Profita, A. Bonanno, L. Siena, A. Bruno, M. Ferraro, A.M. Montalbano, G.D. Albano, L. Riccobono, P. Casarosa, M.P. Pieper, and M. Gjomarkaj Smoke, choline acetyltransferase, muscarinic receptors, and fibroblast proliferation in chronic obstructive pulmonary disease J. Pharmacol. Exp. Ther. 329 2 2009 753 763
33. M. Profita, A. Bonanno, A.M. Montalbano, M. Ferraro, L. Siena, A. Bruno, S. Girbino, G.D. Albano, P. Casarosa, M.P. Pieper, and M. Gjomarkaj Cigarette smoke extract activates human bronchial epithelial cells affecting non-neuronal cholinergic system signalling in vitro Life Sci. 89 1-2 2011 36 43
34. M. Profita, A. Bonanno, A.M. Montalbano, G.D. Albano, L. Riccobono, L. Siena, M. Ferraro, P. Casarosa, M.P. Pieper, and M. Gjomarkaj β2long-acting and anticholinergic drugs control TGF-β1-mediated neutrophilic inflammation in COPD Biochim. Biophys. Acta 1822 7 2012 1079 1089
35. B.J. Proskocil, H.S. Sekhon, Y. Jia, V. Savchenko, R.D. Blakely, J. Lindstrom, and E.R. Spindel Acetylcholine is an autocrine or paracrine hormone synthesized and secreted by airway bronchial epithelial cells Endocrinology 145 756 2004 2498 2506
36. D.F. Rogers Pharmacological regulation of the neuronal control of airway mucus secretion Curr. Opin. Pharmacol. 2 2002 249 255
37. D.F. Rogers Mucociliary dysfunction in COPD: effect of current pharmacotherapeutic options Pulm. Pharmacol. Ther. 18 1 2005 1 8
38. K. Takeyama, B. Jung, J.J. Shim, P.R. Burgel, T. Dao-Pick, I.F. Ueki, U. Protin, P. Kroschel, and J.A. Nadel Activation of epidermal growth factor receptors is responsible for mucin synthesis induced by cigarette smoke Am. J. Physiol. Lung Cell. Mol. Physiol. 280 2001 L165 L172
39. J. Tamaoki, A. Chiyotani, E. Tagaya, N. Sakai, and K. Konno Effect of long term treatment with oxitropium bromide on airway secretion in chronic bronchitis and diffuse panbronchiolitis Thorax 49 1994 545 548
40. D.P. Tashkin, B.R. Celli, S. Senn, D. Burkhart, S. Kesten, S.S. Menjoge, and M. Decramer A 4-year trial of Tiotropium in chronic obstructive pulmonary disease N. Engl. J. Med. 359 2008 1543 1554
41. D.J. Thornton, I. Carlstedt, M. Howard, P.L. Devine, M.R. Price, and J.K. Sheehan Respiratory mucins: identification of core proteins and glycoforms Biochem. J. 316 967 1996 75
42. J. Vestbo, T. Sørensen, P. Lange, A. Brix, P. Torre, and K. Viskum Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial Lancet 355 1999 1819 1823
43. I. Wessler, C.J. Kirkpatrick, and K. Racke The cholinergic 'pitfall': acetylcholine, a universal cell molecule in biological systems, including humans Clin. Exp. Pharmacol. Physiol. 26 1999 198 205
44. L. Wollin, and M.P. Pieper Tiotropium bromide exerts anti-inflammatory activity in a cigarette smoke mouse model of COPD Pulm. Pharmacol. Ther. 23 2010 345 354
45. E.F. Wouters, D.S. Postma, B. Fokkens, W.C. Hop, J. Prins, A.F. Kuipers, H.R. Pasma, C.A. Hensing, and E.C. Creutzberg Withdrawal of fluticasone propionate from combined salmeterol/fluticasone treatment in patients with COPD cause immediate and sustained disease deterioation: a randomised controlled trial Thorax 60 2005 480 487